.Merck beats revenues expectations, rears sales outlook on solid need for leading medications like Keytruda CNBCMerck & Co. (MRK United States) Beats Earnings Projections as Keytruda Sales Growth BloombergMerck Sell: Pharma Titan Posts Powerful Results, But Expectation Tumbles Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps earnings and purchases desires amid Keytruda strong point, yet supplies mixed full-year overview MarketWatch.